« Zurück
Startseite /
IFNA1/IFNA13 Polyclonal Antibody

IFNA1/IFNA13 Polyclonal Antibody

ArtNr	E-AB-52067-20
Hersteller	Elabscience
Menge	20 uL
Quantity options	120 uL 20 uL 200 uL 60 uL
Kategorie	Antibodies Immunohistochemistry ELISA Cardiovascular Research Hypertension Primary Antibodies
Typ	Antibody Polyclonal
Applikationen	IHC
Specific against	Human (Homo sapiens)
Host	Rabbit
Isotype	IgG
Konjugat/Tag	Unconjugated
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	IFL, IFN alpha, IFN alpha 1/13, IFN alpha 1b, IFN alphaD, IFN, IFN-alpha-1/13, IFNA@, IFNA1, IFNA1, IFNA13, Interferon alpha 1, Interferon alpha-1/13, Interferon alpha-D, Interferon alpha1, Interferon, alpha 13, LeIF D
Similar products	IFN, IFNA, IFNA13, IFNA1, Interferon alpha-1/13, Interferon alpha-D, Interferon, IFN alpha, Interferon alpha 1, IFL, LeIF D, IFN-alpha-1/13, IFN alpha 1/13, IFN alpha 1b, IFN alphaD, Interferon alpha1, alpha 13
Versandbedingung	Gekühlt
Gefahren-Info	Comply with cargo safety certificate
Lieferbar
Manufacturer - Category	Primary Antibodies
Manufacturer - Targets	IFNA1/IFNA13
Shipping Temperature	The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions	Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Manufacturer - Research Areas	Cancer, Immunology
Background	IFNA1 (interferon-alpha) is a member of the Type I IFN (1) family best known for their antiviral activity. It is a key cytokine regulating the activity of B cells, T-helper cells (Th cells), cDCs and natural killer cells (NK cells). Interferon-alpha induces B cell maturation into plasma cells and immunoglobulin production. Interferon-alpha plays an important role in the pathogenesis of systemic lupus erythematosus (SLE). Interferon-alpha was the first cytokine to show clinical benefit in the treatment of certain types of cancer, including melanoma, chronic myelogenous leukemia, and renal cancer.
Concentration	0.96 mg/mL
Buffer	PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
Purification Method	Antigen affinity purification
Recommended Dilution	IHC 1:30-1:150
Abbreviation	IFNA1/IFNA13
Clonality	Polyclonal
Immunogen	Synthetic peptide of human IFNA1/IFNA13
Category ID III	Polyclonal Antibodies

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.